These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2949692)

  • 1. Correlates of early disability in Huntington's disease.
    Mayeux R; Stern Y; Herman A; Greenbaum L; Fahn S
    Ann Neurol; 1986 Dec; 20(6):727-31. PubMed ID: 2949692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional decline in Huntington's disease.
    Feigin A; Kieburtz K; Bordwell K; Como P; Steinberg K; Sotack J; Zimmerman C; Hickey C; Orme C; Shoulson I
    Mov Disord; 1995 Mar; 10(2):211-4. PubMed ID: 7753064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unified Huntington's disease rating scale: a follow up.
    Siesling S; van Vugt JP; Zwinderman KA; Kieburtz K; Roos RA
    Mov Disord; 1998 Nov; 13(6):915-9. PubMed ID: 9827615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors contributing to institutionalization in patients with Huntington's disease.
    Rosenblatt A; Kumar BV; Margolis RL; Welsh CS; Ross CA
    Mov Disord; 2011 Aug; 26(9):1711-6. PubMed ID: 21538527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Objective assessment of motor slowness in Huntington's disease: clinical correlates and 2-year follow-up.
    van Vugt JP; Piet KK; Vink LJ; Siesling S; Zwinderman AH; Middelkoop HA; Roos RA
    Mov Disord; 2004 Mar; 19(3):285-97. PubMed ID: 15022182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of adaptive functioning in Huntington's disease.
    Bylsma FW; Rothlind J; Hall MR; Folstein SE; Brandt J
    Mov Disord; 1993 Apr; 8(2):183-90. PubMed ID: 8474487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of neuropathological severity in 100 patients with Huntington's disease.
    Rosenblatt A; Abbott MH; Gourley LM; Troncoso JC; Margolis RL; Brandt J; Ross CA
    Ann Neurol; 2003 Oct; 54(4):488-93. PubMed ID: 14520661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is "subcortical dementia" a recognizable clinical entity?
    Mayeux R; Stern Y; Rosen J; Benson F
    Ann Neurol; 1983 Sep; 14(3):278-83. PubMed ID: 6227275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unified Huntington's Disease Rating Scale: reliability and consistency. Huntington Study Group.
    Mov Disord; 1996 Mar; 11(2):136-42. PubMed ID: 8684382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A shortened version of the motor section of the Unified Huntington's Disease Rating Scale.
    Siesling S; Zwinderman AH; van Vugt JP; Kieburtz K; Roos RA
    Mov Disord; 1997 Mar; 12(2):229-34. PubMed ID: 9087982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Visuospatial cognition in Huntington's disease.
    Mohr E; Brouwers P; Claus JJ; Mann UM; Fedio P; Chase TN
    Mov Disord; 1991; 6(2):127-32. PubMed ID: 1829137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complex movement behaviour and progression of Huntington's disease.
    Andrich J; Saft C; Ostholt N; Müller T
    Neurosci Lett; 2007 Apr; 416(3):272-4. PubMed ID: 17321683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bradykinesia in Huntington's disease. A prospective, follow-up study.
    García Ruiz PJ; Hernández J; Cantarero S; Bartolomé M; Sánchez Bernardos V; García de Yébenez J
    J Neurol; 2002 Apr; 249(4):437-40. PubMed ID: 11967649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behavioural problems in Huntington's disease using the Problem Behaviours Assessment.
    Kingma EM; van Duijn E; Timman R; van der Mast RC; Roos RA
    Gen Hosp Psychiatry; 2008; 30(2):155-61. PubMed ID: 18291297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evolution of locomotion disorders in Huntington's disease].
    Delval A; Krystkowiak P; Blatt JL; Delliaux M; Destée A; Derambure P; Defebvre L
    Neurophysiol Clin; 2008 Apr; 38(2):117-25. PubMed ID: 18423332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship between CAG repeat length and clinical progression in Huntington's disease.
    Ravina B; Romer M; Constantinescu R; Biglan K; Brocht A; Kieburtz K; Shoulson I; McDermott MP
    Mov Disord; 2008 Jul; 23(9):1223-7. PubMed ID: 18512767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Huntington's disease in Venezuela: 7 years of follow-up on symptomatic and asymptomatic individuals.
    Penney JB; Young AB; Shoulson I; Starosta-Rubenstein S; Snodgrass SR; Sanchez-Ramos J; Ramos-Arroyo M; Gomez F; Penchaszadeh G; Alvir J
    Mov Disord; 1990; 5(2):93-9. PubMed ID: 2139171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of the striatum in rule application: the model of Huntington's disease at early stage.
    Teichmann M; Dupoux E; Kouider S; Brugières P; Boissé MF; Baudic S; Cesaro P; Peschanski M; Bachoud-Lévi AC
    Brain; 2005 May; 128(Pt 5):1155-67. PubMed ID: 15788544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parameter-based assessment of spatial and non-spatial attentional deficits in Huntington's disease.
    Finke K; Bublak P; Dose M; Müller HJ; Schneider WX
    Brain; 2006 May; 129(Pt 5):1137-51. PubMed ID: 16504973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The unified Huntington's Disease Rating Scale for advanced patients: validation and follow-up study.
    Youssov K; Dolbeau G; Maison P; Boissé MF; Cleret de Langavant L; Roos RA; Bachoud-Lévi AC
    Mov Disord; 2013 Dec; 28(14):1995-2001. PubMed ID: 24123464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.